Elfant A B, Bourke M J, Alhalel R, Kortan P P, Haber G B
Centre for Therapeutic Endoscopy and Endoscopic Oncology, Wellesley Hospital, University of Toronto, Ontario, Canada.
Am J Gastroenterol. 1996 Aug;91(8):1499-502.
Many centers routinely admit patients for observation after endoscopic therapy of choledocholithiasis although this is contrary to the current mandate for cost containment. The purpose of this study was to determine the safety, success, and complication rates of outpatient therapeutic ERCP in the management of choledocholithiasis.
Over a 4-month period, 97 consecutive outpatients undergoing endoscopic treatment for choledocholithiasis were enrolled in a prospective manner. Each subject was observed 1-3 h postprocedure before discharge with follow-up at 10 days.
Successful endoscopic management of choledocholithiasis was achieved in 100% of patients. Complication rates were as follows: pancreatitis (2.1%), postsphincterotomy bleeding (3.2%), perforation (0%), and sepsis (0%). One patient required admission during the observation period, and two others with pancreatitis were readmitted within 24 h of discharge. There was no apparent adverse clinical outcome related to this policy.
Endoscopic therapy of choledocholithiasis may be performed safely on an outpatient basis, realizing significant cost savings.
尽管目前要求控制成本,但许多中心在胆总管结石内镜治疗后仍常规收治患者进行观察。本研究的目的是确定门诊治疗性内镜逆行胰胆管造影术(ERCP)治疗胆总管结石的安全性、成功率和并发症发生率。
在4个月的时间里,前瞻性纳入了97例连续接受内镜治疗胆总管结石的门诊患者。每位受试者在术后1 - 3小时进行观察,然后出院,并在10天后进行随访。
100%的患者实现了胆总管结石的成功内镜治疗。并发症发生率如下:胰腺炎(2.1%)、括约肌切开术后出血(3.2%)、穿孔(0%)和败血症(0%)。1例患者在观察期内需要住院,另外2例胰腺炎患者在出院后24小时内再次入院。该策略未产生明显不良临床后果。
胆总管结石的内镜治疗可以在门诊安全进行,显著节省成本。